These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6426474)

  • 1. Low sulfated glycosaminoglycans are excreted in patients with the Lowe syndrome.
    Kieras FJ; Houck GE; French JH; Wisniewski K
    Biochem Med; 1984 Apr; 31(2):201-10. PubMed ID: 6426474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of a large amount of bound sialic acid and of under sulfated chondroitin sulfate A by patients with the Lowe syndrome.
    Akasaki M; Fukui S; Sakano T; Tanaka T; Usui T; Yamashina I
    Clin Chim Acta; 1978 Oct; 89(1):119-25. PubMed ID: 152172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary acid glycosaminoglycans in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):225-34. PubMed ID: 734647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low urinary excretion of heparan sulfate in three patients with Lowe's syndrome.
    Yokoi T; Uozaki T; Kasei M; Sato T; Taniguchi N
    Clin Chim Acta; 1981 Oct; 116(2):153-60. PubMed ID: 6457705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of acid glycosaminoglycans and hydroxyproline in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):215-23. PubMed ID: 734646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-sulfated chondroitin sulfate in human blood and urine.
    Hata RI; Ohkawa SI; Nagai Y
    Biochim Biophys Acta; 1978 Oct; 543(2):156-66. PubMed ID: 728458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural, neurological, and glycosaminoglycan abnormalities in lowe's syndrome.
    Wisniewski KE; Kieras FJ; French JH; Houck GE; Ramos PL
    Ann Neurol; 1984 Jul; 16(1):40-9. PubMed ID: 6087720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC glycosaminoglycan analysis in patients with Graves' disease.
    Hansen C; Fraiture B; Rouhi R; Otto E; Förster G; Kahaly G
    Clin Sci (Lond); 1997 May; 92(5):511-7. PubMed ID: 9176026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lowe syndrome--a case study with special reference to urinary acidic mucopolysaccharides and kidney biopsy].
    Nagata T; Sakuma T; Yamaguchi A; Nagai H; Nagasawa S
    Nihon Jinzo Gakkai Shi; 1975 Mar; 17(3):147-59. PubMed ID: 138759
    [No Abstract]   [Full Text] [Related]  

  • 10. Polydispersity of glycosaminoglycans in normal human urine.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 Aug; 131(4):327-37. PubMed ID: 6781104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
    Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
    Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias.
    Dietrich CP; Martins JR; Sampaio LO; Nader HB
    Lab Invest; 1993 Apr; 68(4):439-45. PubMed ID: 8479152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionation with ethanol of human urinary glycosaminoglycans.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 May; 131(1):23-8. PubMed ID: 6773184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
    Satake S; Ototani N; Isemura M; Yosizawa Z
    Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues.
    Murata K; Yokoyama Y
    Atherosclerosis; 1989 Jul; 78(1):69-79. PubMed ID: 2502994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, identification, and quantitation of urinary glycosaminoglycans.
    Lee EY; Kim SH; Whang SK; Hwang KY; Yang JO; Hong SY
    Am J Nephrol; 2003; 23(3):152-7. PubMed ID: 12646785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and secretion of glycosaminoglycans in cultured retinal pigment epithelium.
    Stramm LE
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):618-27. PubMed ID: 3104227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired synthesis of intracellular heparan sulfate in skin fibroblasts of Lowe's syndrome.
    Yokoi T; Taniguchi N; Ikawa K
    J Lab Clin Med; 1982 Sep; 100(3):461-8. PubMed ID: 6213727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.
    Murata K; Takeda M
    Clin Chim Acta; 1980 Nov; 108(1):49-59. PubMed ID: 6778637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.